Overview
Announcements

Ordinary Adjustment | Solactive US CNS Therapeutics Index | Effective Date 13th June 2025

Solactive US CNS Therapeutics Index:

In the ordinary adjustment, the following composition will be implemented effective open 13th June 2025:

ACADIA PHARMACEUTICALS INC
ALKERMES PLC
ANAVEX LIFE SCIENCES CORP
AVADEL PHARMACEUTICALS PLC
AXSOME THERAPEUTICS INC
BIOGEN INC
DENALI THERAPEUTICS INC
ELI LILLY & CO
HARMONY BIOSCIENCES HOLDINGS INC
JAZZ PHARMACEUTICALS PLC
NEUROCRINE BIOSCIENCES INC
NEW BIOHAVEN
PTC THERAPEUTICS INC
Praxis Precision Medicines Inc
SAREPTA THERAPEUTICS INC
SCHOLAR ROCK HOLDING CORP
SUPERNUS PHARMACEUTICALS INC
UNIQURE B.V.
VERTEX PHARMACEUTICALS INC
XENON PHARMACEUTICALS INC